E-cadherin expression in tumours of patients who were disease free was significantly more compared to those with metastatic disease, local recurrence or dying from breast cancer (Disease free vs. poor outcome (metastatic disease and/or local recurrence and/or death from breast cancer) p = 0.012). Here, CDH1 is linked to metastatic neoplasm.